Skip to main content
News & Events

Recent news and forthcoming events

Keep up to date with Genesis Research Group's recent news and live events. Discover at which pharmaceutical, medical device, and biotech events you can catch up with our team.

Genesis Research at ISPOR

Recent news and live events

January 17, 2024 in News & Events

Webinar – Fit-for-purpose matchmaking: A data selection and RWE approach for both regulatory and HTA audiences

On 15 February 2024, Carole Longson and Allie Sosinsky of Genesis Research Group, a leading global provider of tech-enabled real-world evidence, market access, and HEOR solutions, will present a webinar…
Read More
January 25, 2023 in News & Events

Genesis Research Group strengthens Board of Directors with appointments of Professor Carole Longson MBE and Dr. S. Yin Ho, M.D., M.B.A.

Genesis Research Group, a leading provider of tech-enabled Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) services, has announced the appointment of Professor Carole Longson MBE and Dr.…
Read More
October 5, 2022 in News & Events

Don’t miss our insights and evidence webinar

Join Priti Jhingran of Genesis Research and Tijana Ignjatovic of Market Access Transformation (MAT) for their webinar 'Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to Achieve Optimal Access' at…
Read More
September 25, 2022 in News & Events

Leading pharmaceutical executive Jennifer Fillman joins Genesis Research Group as Chief Financial Officer

International health economics and outcomes research (HEOR) and real-world evidence (RWE) organization Genesis Research Group has announced the appointment of Jennifer Fillman as its new Chief Financial Officer. Prior to…
Read More
August 17, 2022 in News & Events

Genesis Research Group and Syapse combine forces to offer RWE and data to oncology innovators

Genesis Research Group is delighted to announce a strategic partnership with Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world…
Read More
July 15, 2022 in News & Events

Genesis Research Group and COS announce innovative partnership

We are delighted to announce an exciting new partnership with Clinical Outcomes Assessment (COA) specialist Clinical Outcomes Solutions (COS). As the regulatory landscape with respect to RWE continues to evolve,…
Read More
June 10, 2022 in News & Events

Genesis Research Group at ISPOR 2022

From May 16-18, 2022, the Genesis Research Group leadership, including Joseph DiCesare, Frank A. Corvino, Marlene Smurzynski, Chris L. Pashos, Deborah Casso, Stephen Ralston, Weiying Wang, Julie Munakata, and Michael…
Read More
May 10, 2022 in News & Events

Genesis Research Group acquires Market Access Transformation, a leading provider of technology-enabled payer research platforms

Genesis Research Group, a leading provider of tech-enabled Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) services, has acquired Market Access Transformation (“MAT”), a leading provider of technology-enabled…
Read More
March 10, 2022 in News & Events

Genesis Research Group at World EPA Congress 2022

Through 22-24 March, Chris L. Pashos, Lucy Nelson, Stephen Ralston, Susan Oliveria and Richard Chumbley visited Amsterdam to represent Genesis Research Group at the World EPA Congress 2022, Europe's largest…
Read More

Upcoming events

Webinar

Fit-for-purpose matchmaking: A data selection and RWE approach for both regulatory and HTA audiences.

15 February
Register for online access

World EPA Congress

12-13 March
Amsterdam, Netherlands

ISPOR 2024

05-08 May
Atlanta, US

Arrange a meeting

For press and media inquiries, please email Richard Chumbley: rchumbley@genesisrg.com.

Want to hear about our latest news, webinars and events?

Sign up for our newsletter

Headquarters:

HOBOKEN
111 River Street, Suite 1120
Hoboken, New Jersey 07030, US